U.S. FDA panel to vote whether diabetes drug cuts cardiac death

June 24 (Reuters) - An advisory panel to the U.S. Food and

Drug Administration will be asked to vote next week on whether a

diabetes drug made by Eli Lilly & Co and Boehringer

Ingelheim cuts the risk...

Read more